Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.
The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
GlaxoSmithKline and Genmab refocus development programme for ofatumumab in autoimmune indications
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
[Evaluation and quantification of spasticity: a review of the clinical, biomechanical and neurophysiological methods].
Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.
Immune status following alemtuzumab treatment in human CD52 transgenic mice.
Estimating Time to Disease Progression Comparing Transition Models and Survival Methods-An Analysis of Multiple Sclerosis Data.
Genetics of multiple sclerosis: swimming in an ocean of data.
Colestipol May Quickly Eliminate Teriflunomide
1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.
Good Early Results for HERV Suppressor in MS
IFNγ-stimulated dendritic cell exosomes as a potential therapeutic for remyelination.
The role of T cell apoptosis in nervous system autoimmunity.
Treatment of acute transverse myelitis and its early complications.
Effect of Rituximab in Patients With Leucine-Rich, Glioma-Inactivated 1 Antibody-Associated Encephalopathy.
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study).
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.
Pharmacokinetic properties and metabolism of idebenone.
Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study.
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
Tecfidera(®): an approach for repurposing.
CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.
Pages
« first
‹ previous
…
82
83
84
85
86
87
88
89
90
…
next ›
last »